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seem to be in better agreement with the IAEA TRS-398 values 
currently in use, than those of cylindrical chambers. 
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Purpose or Objective: Automated planning (AP) aims to 
simplify the treatment planning process by eliminating user 
variability. We performed a detailed plan comparison based 
on clinical objectives and dose-volume histogram (DVH) 
parameters in a group of stereotactic body radiation therapy 
(SBRT) lung cancer patients. 
 
Material and Methods: Between March 2012 and May 2015, 
55 lung cancer patients were treated with SBRT at our 
institution. A total dose of 60 Gy in 3 fractions was 
prescribed to the PTV (D95). For each patient, an IMRT plan 
was created using in-house developed optimization software 
by manually tweaking a set of optimization objectives during 
several iterations. Final dose calculation was performed in 
Pinnacle 9.8 (Philips Medical Systems Inc, USA). These plans 
are further referred to as the manual plans (MP). 
For each patient, an additional plan was created 
retrospectively using the Pinnacle 9.10 Auto-Planning 
software with a template representing the clinical objectives 
for the following structures: GTV, PTV, lungs minus GTV, 
spinal cord, esophagus, heart, aorta, trachea, main stem 
bronchus and chest wall. Using automatic optimization tuning 
methods, an automated plan (AP) was created for each 
patient using the same IMRT beam directions as for the MP. 
No additional manual tweaking whatsoever was performed. 
For all of the above-mentioned structures the following DVH 
parameters were included in our analysis: D99, D98, D95, 
D90, D50, D5, D2 (in which xx% of the PTV volume receives a 
dose of at least Dxx) and Dmean. For the organs at risk (OAR) 
V5, V10 and V20 were also included (in which Vxx is the 
volume receiving at least xx Gy). The acceptability of each 
plan was judged against our clinical objectives (result: pass, 
minor deviation or fail). Additionally, pairwise comparisons of 
the DVH parameters were performed using paired, two-sided 
t-tests between the MPs and APs. 
 
Results: Three APs failed in terms of our clinical objectives 
(1 plan: heart D2, 2 plans: chest wall D2), while 13 plans 
showed a minor deviation (12 plans: lungs minus GTV V20, 1 
plan: chest wall D2). None of the MPs failed our clinical 
objectives, but 9 also showed a minor deviation (8 plans: 
lungs minus GTV V20, 1 plan: PTV D99). The graph shows 
average values over all patients of the dose (in Gy) –volume 
(in %) parameters for which statistically significant (p < 0,05) 
differences were found between the MPs and APs. Top: GTV 
and PTV; bottom: clinical OAR objectives. All plans were 
normalized to PTV D95 = 60 Gy. 
 
 
Conclusion: Without user intervention, AP resulted in plans 
that comply with our clinical objectives for almost all 
patients. Some APs may require slight additional manual 
tweaking. From a statistical point of view, AP delivers 
significantly less dose to the OARs, while preserving target 
coverage. In the near future, all plans will be blindly 
evaluated by three experienced radiation oncologists to 
assess the clinical significance of the observed statistical 
differences. 
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Purpose or Objective: The ViewRay MRI-Co60 hybrid system 
(MRIdian) allows MRI based targeting, autosegmentation and 
direct planning for numerous anatomical districts. Our 
department is implementing this technology and, up to date, 
we are comparing planning procedures to our clinical 
standards in order to define which districts could take 
advantage from the use of the MRIdian technology. Aim of 
this investigation was to assess the impact of the MRIdian 
radiation therapy system through a planning analysis for 
rectal cancer treatments. 
 
Material and Methods: Ten sets of 3 plans (MRIdian, RapidArc 
and 5 beams sliding windows IMRT) were calculated for 10 
patients affected by locally advanced rectal cancer (cT3-cT4; 
cN0, cN+). ROIs were contoured on Eclipse TPS. RapidArc (6-
15 MV) and 5 beams (6-15 MV) sliding windows IMRT 
treatment plans were calculated on Eclipse according to our 
QA protocols. The PTV1 (CTV1+7 mm margin) was 
represented by tumor+1.5 cm margin craniocaudally and 
correspondent mesorectum, the PTV2 (CTV2 + 7 mm margin) 
by mesorectum in toto and pelvic nodes. The body, the bowel 
bag and the bladder were the OaR considered. The 
prescribed dose for PTV2 was 45 Gy and 55 Gy for PTV1 
through simultaneous integrated boost. The PTV V95 and 
OaRs QUANTEC dose constraints on the DVHs and Wu’s 
homogeneity indexes (HI) were considered for the QA of the 
plans. The structure sets were then uploaded on the MRIdian 
TPS and Co60 step and shoot IMRT plans (7 groups of 3 fields) 
were calculated. The DHVs and HIs were then compared to 
the RapidArc and IMRT plans in order to evaluate MRIdian’s 
performances. 
 
Results: MRIdian showed a better HI when compared to the 
other techniques for PTV1, while this advantage could not be 
appreciated for PTV2, even if a better PTV2 V100 (45 Gy) was 
observed. Comparable mean doses for the bladder were 
registered, while a higher bowel V45 was observed (even if 
still in the constraints limits). Low dose body V5 was higher 
